Grants

BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) (RFA-NS-24-016)

Tools

Back to the Top

Sponsor

National Institutes of Health

Award

Applicants must not exceed $500,000 in direct costs per year for the UG3 phase and should rarely exceed $1,500,000 direct costs per year for the UH3 phase.

Due Date

Multiple due dates; see announcement.

View Grant